DE69937341D1 - Verbesserungen in oder bezüglich zu kontrastmittel - Google Patents

Verbesserungen in oder bezüglich zu kontrastmittel

Info

Publication number
DE69937341D1
DE69937341D1 DE69937341T DE69937341T DE69937341D1 DE 69937341 D1 DE69937341 D1 DE 69937341D1 DE 69937341 T DE69937341 T DE 69937341T DE 69937341 T DE69937341 T DE 69937341T DE 69937341 D1 DE69937341 D1 DE 69937341D1
Authority
DE
Germany
Prior art keywords
dispersed
gas
preparations
perfusion
material present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937341T
Other languages
German (de)
English (en)
Inventor
Morten Eriksen
Helge Tolleshaug
Roald Skurtveit
Alan Cuthbertson
Jonny Ostensen
Sigmund Frigstad
Pal Rongved
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare AS filed Critical GE Healthcare AS
Application granted granted Critical
Publication of DE69937341D1 publication Critical patent/DE69937341D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69937341T 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel Expired - Lifetime DE69937341D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents
PCT/GB1999/001221 WO1999053963A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
DE69937341D1 true DE69937341D1 (de) 2007-11-29

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937341T Expired - Lifetime DE69937341D1 (de) 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel

Country Status (17)

Country Link
US (1) US20040146462A1 (https=)
EP (1) EP1073473B1 (https=)
JP (1) JP2002512206A (https=)
KR (1) KR20010042915A (https=)
CN (1) CN1306442A (https=)
AT (1) ATE375806T1 (https=)
AU (1) AU3617299A (https=)
BR (1) BR9909822A (https=)
CA (1) CA2329175A1 (https=)
DE (1) DE69937341D1 (https=)
GB (1) GB9808599D0 (https=)
HU (1) HUP0102878A3 (https=)
IL (1) IL139147A0 (https=)
NO (1) NO20005250L (https=)
PL (1) PL343464A1 (https=)
WO (1) WO1999053963A1 (https=)
ZA (1) ZA200005789B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
KR101280760B1 (ko) 2002-11-29 2013-07-05 지이 헬스케어 에이에스 초음파 조영 물질
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP4670083B2 (ja) 2003-02-04 2011-04-13 ブラッコ・シュイス・ソシエテ・アノニム 超音波造影剤およびその製造方法
JP2007515471A (ja) * 2003-12-22 2007-06-14 ブラッコ・リサーチ・ソシエテ・アノニム 造影イメージング用の活性成分を有する気体封入マイクロベシクルのアセンブリー
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
WO2009097277A1 (en) * 2008-02-01 2009-08-06 Trustees Of Boston University Cationic contrast agents and methods of use thereof
AU2009241762B2 (en) * 2008-05-02 2015-07-16 Celsense Inc. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
EP2470287A4 (en) 2009-08-28 2015-01-21 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR PRODUCING GAS-FILLED MICROBUBBLES
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
HUE060034T2 (hu) * 2013-09-27 2023-01-28 Exact Therapeutics As Ultrahanggal közvetített hatóanyag leadás
AP2016009276A0 (en) 2013-12-19 2016-06-30 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
CN110913769A (zh) * 2017-07-09 2020-03-24 利兰斯坦福初级大学董事会 利用频谱合成来减少斑点的超声成像
EP3678712A4 (en) * 2017-09-07 2021-06-02 Imbiotechnologies Ltd. EMBOLIC AGENTS SENSITIVE TO SOUND
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
CN114760989A (zh) 2019-10-25 2022-07-15 精准医疗股份有限公司 胰腺癌的治疗
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422B (en) 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2629999B (en) 2021-04-21 2025-03-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
CN113598820B (zh) * 2021-08-18 2025-09-23 南京超微影医疗科技有限公司 超声成像方法及装置
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose
CN116271187B (zh) * 2023-03-21 2025-07-04 湖北科技学院 双模态显影温敏Pickering乳液介入栓塞材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
EP1550464A1 (en) * 1993-07-30 2005-07-06 IMCOR Pharmaceutical Co. Stabilized microbubble composition for ultrasound
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
TR199901544T2 (xx) * 1996-10-21 1999-09-21 Nycomed Imaging As Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
EP0963209A2 (en) * 1996-10-28 1999-12-15 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018497A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents

Also Published As

Publication number Publication date
CN1306442A (zh) 2001-08-01
JP2002512206A (ja) 2002-04-23
US20040146462A1 (en) 2004-07-29
HUP0102878A2 (hu) 2002-03-28
AU3617299A (en) 1999-11-08
NO20005250D0 (no) 2000-10-19
BR9909822A (pt) 2000-12-19
PL343464A1 (en) 2001-08-13
ZA200005789B (en) 2001-07-30
CA2329175A1 (en) 1999-10-28
ATE375806T1 (de) 2007-11-15
WO1999053963A1 (en) 1999-10-28
KR20010042915A (ko) 2001-05-25
IL139147A0 (en) 2001-11-25
EP1073473A1 (en) 2001-02-07
GB9808599D0 (en) 1998-06-24
NO20005250L (no) 2000-12-18
HUP0102878A3 (en) 2002-12-28
EP1073473B1 (en) 2007-10-17

Similar Documents

Publication Publication Date Title
DE69937341D1 (de) Verbesserungen in oder bezüglich zu kontrastmittel
WO1998017324A3 (en) Improvements in or relating to contrast agents
WO2004017907A3 (en) Blood clot-targeted nanoparticles
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
SE8705043D0 (sv) Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
PT1042001E (pt) Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua
BR9814924A (pt) Microgrânulos de omeprazol, processo de preparação dos mesmos, e, preparações farmacêuticas
Siim et al. Scintigraphic imaging of the hypoxia marker 99mtechnetium-labeled 2, 2′-(1, 4-diaminobutane) bis (2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; Prognox): noninvasive detection of tumor response to the antivascular agent 5, 6-dimethylxanthenone-4-acetic acid
CA2383600A1 (en) Method for determining viability of a myocardial segment
SE9402880D0 (sv) New peptide derivatives
Tsuru et al. Characterization of histamine receptors in isolated rabbit veins.
GB9808582D0 (en) Improvements in or relating to contrast agents
Møller et al. Neurohumoral fluid regulation in chronic liver disease
EA200101106A1 (ru) Фармацевтический комплекс
Flynn et al. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
MX9205527A (es) Uso de 14-aminoesteroides para disminuir la velocidad de progrecion de daños estructurales al miocardio caracteristicos de la insuficiencia cardiaca congestiva
KR900017599A (ko) 종양 치료용 약학 조성물
Glover et al. Myocardial uptake of Tc-99m-NOET during adenosine hyperemia in dogs with mild to moderate coronary stenoses
Khaw et al. A novel antimyosin immunoliposome treatment for preservation of dying myocytes: Tritiated thymidine uptake studies
Johnson III et al. Distribution of Tc-99m BMS-194796 in normal and ischemic myocardium compared with tissue flow and oxygen
Gnecchi-Ruscone et al. Ergotamine limits hyperemic myocardial blood flow in humans
Evans et al. Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats
Struthers et al. Nifedipine does not influence adrenaline induced hypokalaemia in man

Legal Events

Date Code Title Description
8332 No legal effect for de